08Jun
FDA Signals a Deliberative Approach to Cannabis at Public Hearing
While it was ostensibly convened to gather scientific input from stakeholders on how to appropriately regulate cannabis-infused products, the Food and Drug Administration (FDA) also used the May 31, 2019 public hearing as a platform to issue a call...
By:
Wilson Sonsini Goodrich & Rosati
Related
In today’s edition of Daily Compliance News: China says HSBC set ‘trap’ for Huawei. (WSJ) Lay-of...
Read More >
• The Chicago Fair Workweek Ordinance will affect Chicago employers across a wide reach of industri...
Read More >
On June 10, Gov. Ron DeSantis signed HB 1339 into law, making it easier to develop affordable housin...
Read More >
Due to the developing COVID-19 coronavirus pandemic, beginning Tuesday, March 17, 2020, the Federal ...
Read More >
The battle over the scope and applicability of the so-called “ABC test” in determining California ...
Read More >
Massage Therapy Company Fired Employee Because She Was Pregnant, Federal Agency Charged - ORLANDO ...
Read More >